Oncology & Cancer
Prostate cancer treatment: An encouraging combination therapy
A trio of drugs could delay the progression of metastatic castration-resistant prostate cancer.
Nov 3, 2021
0
12
Page 3 - News tagged with castration
Oncology & Cancer
ATR inhibitor RP-3500 demonstrates safety and early clinical benefit
In a first-in-human, Phase I trial, researchers at The University of Texas MD Anderson Cancer Center discovered that ATR inhibitor RP-3500 was safe and well tolerated with promising clinical benefit. Principal investigator ...
Oct 8, 2021
0
29
Oncology & Cancer
Overcoming a newly recognized form of resistance to modern prostate cancer drugs
Cancer cells have an uncanny ability to evolve and adapt to overcome the treatments used against them.
Jun 18, 2021
0
16
Medical research
Research uncovers additional treatment option in prostate cancer
The standard treatment for advanced metastatic prostate cancer (PCa) is androgen deprivation therapy (ADT). And even if this is efficient in the short term, 1/3 of PCa will become resistant to ADT and develop castration-resistant ...
Mar 29, 2021
0
88
Oncology & Cancer
Prostate cancer uses metabolic switch to thrive after hormone therapy
Studying the cellular metabolism of prostate cancer, a team of Duke Health-led researchers identified a key reason hormone therapies eventually fail, while also laying out a way to bypass the problem using an entirely new ...
Mar 22, 2021
0
218
Oncology & Cancer
Immunotherapy offers hope for prostate cancer treatment
An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant prostate cancer. This is the finding of the long-term analyses of an international phase ...
Sep 29, 2020
0
9
Oncology & Cancer
Darolutamide boosts survival in nonmetastatic prostate cancer
(HealthDay)—For men with nonmetastatic, castration-resistant prostate cancer, the risk for death is significantly lower for those receiving darolutamide versus placebo, according to a study published in the Sept. 10 issue ...
Sep 15, 2020
0
3
Oncology & Cancer
Researchers identify possible drug target for prostate cancer
Researchers from Boston University School of Medicine (BUSM) have discovered that the protein BRD4 could be an important new target to prevent castration-resistant prostate cancer metastases.
Jul 21, 2020
0
163
Medications
Relugolix superior to leuprolide in advanced prostate cancer
(HealthDay)—For men with advanced prostate cancer, the oral gonadotropin-releasing hormone (GnRH) antagonist relugolix maintains testosterone suppression compared with the GnRH agonist leuprolide, while enzalutamide is ...
May 29, 2020
0
5
Surgery
Castration of men was based on knowledge of the female body
Many men know that benign prostate enlargement can affect their quality of life. The prostate, normally the size of a walnut, can swell up, causing pain and a need to urinate frequently. Today there is a range of treatment ...
Dec 10, 2019
0
11
